Aptean Further Expands Healthcare Offerings With Acquisition of Connect
ALPHARETTA, Ga., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Aptean, a leading global provider of mission-critical enterprise software solutions, has acquired the Connect segment of Influence Health to add to its growing suite of products that serve the healthcare industry and public sector.
Connect, a division of Influence Health, offers physicians and clinicians secure access to patient data from a variety of different systems, including EHR databases, laboratory results systems, pharmacies and other clinical databases, and aggregates the data via a web-based solution to provide a comprehensive view of a patient's medical history. The solution also offers audit reporting capabilities for healthcare organizations to protect patient privacy and ensure data security.
"The need to safely access the growing amount of electronic health data is critically important to the healthcare industry throughout the world," said Aptean CEO Kim Eaton. "With a comprehensive view of such data, doctors can do their jobs more effectively and patients can receive better care. The addition of Connect and its significant capabilities to our expanding portfolio is an important milestone in Aptean's evolution as a solutions provider."
"As sales momentum for Influence Health's Consumer Experience Platform continues to accelerate with healthcare marketers and executives, we are pleased to have found in Aptean an acquirer that will bring to Connect the focus and resources required to take advantage of the growth potential in the clinical market," said Mike Nolte, CEO of Influence Health. "Our team is confident that the Connect business will thrive and expand to new customers under the excellent leadership of Aptean."
The purchase of Connect is part of Aptean's focus on the public sector and healthcare markets and is the company's 14th acquisition since 2015. Medworxx, which offers knowledge management, patient flow and patient safety solutions for healthcare organizations, joined Aptean in 2015 as the company's entry into the healthcare arena.
In the publicly funded healthcare system in Canada, provincial and territorial governments are responsible for the management, organization and delivery of healthcare services. Under that system, Connect provides a federated health information exchange for hospitals and medical providers in Ontario, Canada.
Employees focused on the Connect product have joined Aptean and will continue to work in their current locations. Financial terms of the sale will not be disclosed.
ABOUT INFLUENCE HEALTH
Influence Health provides the healthcare industry's only integrated digital marketing and patient engagement platform. The Influence Health platform enables providers, employers and payers to positively influence consumer decision making and health behaviors well beyond the physical care setting through personalized and interactive multi-channel engagement enabling population health management. Since 1996, the Birmingham, AL-based company has helped more than 1,100 provider organizations influence consumers in a way that is transformative to financial and quality outcomes. For more information visit influencehealth.com.
Aptean is a leading global provider of mission-critical enterprise software solutions. We build, acquire and integrate industry-focused solutions to support the evolving operational needs of our customers, enabling them to increase operational efficiencies and improve customer satisfaction and loyalty. To learn how Aptean can help your organization stay at the forefront of your industry, visit www.aptean.com.
Aptean is a trademark of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.
FOR MORE INFORMATION
Stephanie Zercher, Aptean
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aptean via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Navigators to Acquire Belgian Specialty Insurer18.12.2017 07:30 | Pressmeddelande
STAMFORD, CT, December 18, 2017 - The Navigators Group, Inc. (NASDAQ:NAVG) today announced that it has entered into a share purchase agreement for the purchase of all of the shares of Assurances Continentales - Continentale Verzekeringen NV ("ASCO") and Bracht, Deckers & Mackelbert NV ("BDM"). ASCO and BDM are both based in Antwerp, Belgium. The proposed acquisition is part of Navigators' strategy of expanding its well-established specialty insurance expertise to more brokers and insureds across Europe. ASCO is a specialty insurance company offering marine and property and casualty insurance. BDM is an insurance underwriting agency that underwrites risk coverage in niche markets on behalf of ASCO and a number of major international insurers. Additionally, as part of the transaction, Navigators will acquire all the shares of Canal Re SA, a Luxembourg reinsurance company that is a wholly-owned subsidiary of ASCO. The acquisition reinforces Navigators' presence in the European Un
Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit15.12.2017 22:04 | Pressmeddelande
Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Ltd. (Nasdaq:OXFD) and QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt Stock Exchange:QIA) announced today that they have reached a settlement in the lawsuit in the U.S. District Court for the District of Massachusetts in Boston (15-cv-13124-NMG) alleging patent infringement in relation to QIAGEN's QuantiFERON®-TB Gold and QuantiFERON®-TB Gold Plus products. Under terms of the agreement, all pending claims between Oxford and QIAGEN and the co-defendants have been resolved. As part of the settlement, Oxford has granted QIAGEN a royalty-free, non-exclusive license that extends to all current and future customers of QuantiFERON-TB Gold and QuantiFERON-TB Gold Plus in exchange for a one-time, lump-sum payment of $27.5 million. The settlement includes general
Algeco Scotsman Announces Acquisition of Iron Horse Ranch15.12.2017 21:32 | Pressmeddelande
BALTIMORE, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Algeco/Scotsman Holding S.à r.l. (together with its subsidiaries, the "Algeco Group") today announced the successful closing of the acquisition by the Algeco Group's subsidiary, Target Logistics Management, LLC ("Target Logistics"), of Iron Horse Ranch from funds managed by TDR Capital LLP ("TDR"). The acquisition solidifies Target Logistics' position as the single largest provider of turnkey workforce housing in the U.S., including a network of eight lodges and 2,119 beds in the Permian Basin. With the acquisition, Target Logistics' Permian Basin lodge network now includes Texas lodges in Pecos, Mentone, San Angelo and two in Odessa, along with two lodges in Carlsbad and Lovington, New Mexico. Additionally, Target Logistics adds Eagle Ford lodges in Cameron and Yorktown, Texas. Diarmuid Cummins, CEO Algeco Scotsman: "Today we announce the completion of the second of two strategic acquisitions which we flagged earlier
Repurchase of own shares in Momentum Group AB (publ)15.12.2017 15:25 | Pressmeddelande
In accordance with the authorisation issued by the Extraordinary General Meeting of Shareholders held on 28 November 2017, Momentum Group AB (publ) has repurchased 28,800 Class B shares at an average price of SEK 103.34 per share. After the repurchase, Momentum Group AB's current holding of treasury shares amounts to 28,800 Class B shares, corresponding to 0.1 percent of the total number of shares and 0.1 percent of the total number of votes. The total number of shares in Momentum Group AB, including those held by the Company, amounts to 28,265,416, of which 1,062,436 are Class A shares and 27,202,980 are Class B shares. The total number of votes in Momentum Group AB is 37,827,340. Stockholm, 15 December 2017 Momentum Group AB (publ) For further information, please contact: Mats Karlqvist, Head of Investor Relations - Tel: +46 70 660 31 32 This information was submitted for publication on 15 December 201
Återköp av egna aktier i Momentum Group AB (publ)15.12.2017 15:25 | Pressmeddelande
I enlighet med bemyndigandet från den extra bolagsstämman den 28 november 2017 har Momentum Group AB (publ) återköpt 28 800 aktier av serie B till en genomsnittskurs av 103,34 SEK per aktie. Momentum Group ABs aktuella innehav av egna aktier efter återköpet uppgår till 28 800 aktier av serie B, vilket motsvarar 0,1 procent av totalt antal aktier och 0,1 procent av totalt antal röster. Det totala antalet aktier i Momentum Group AB, inklusive de av bolaget ägda aktierna, uppgår till 28 265 416 st, av vilka 1 062 436 är aktier av serie A och 27 202 980 är aktier av serie B. Det totala antalet röster i Momentum Group AB är 37 827 340. Stockholm den 15 december 2017 Momentum Group AB (publ) För ytterligare information vänligen kontakta: Mats Karlqvist, Head of Investor Relations - telefon 070-660 31 32 Informationen lämnades för offentliggörande den 15 december 2017 kl. 15:15 CET.
Elemica Named to Food Logistics Top 100 List15.12.2017 13:55 | Pressmeddelande
11th Consecutive Win for Delivering Value Across Clients' Supply Chains WAYNE, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Elemica, the leading Business Network for the process industries, announces the company has been named to Food Logistics magazine's FL100+ Award for the 11th year. The FL100+ list recognizes leading software and technology providers in the food and beverage industry. Elemica was chosen for helping agricultural and food ingredient businesses conduct more efficient and error free commerce across their community of suppliers, customers and logistics providers - delivering value through lower operating expenses and working capital costs. "We are honored to be included for the past eleven years on the Food Logistics FL100+ list for helping companies improve efficiencies and generate value from their supply chains," said John Blyzinskyj, CEO of Elemica. "Automating business processes, enabling end-to-end visibility, and providing a platform for
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum